Evidence map›Paper›PMID 34559403›Full record

ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2021

Correction to: Lower COVID-19 Mortality in Patients with Type 2 Diabetes Mellitus Taking Dipeptidyl Peptidase-4 Inhibitors: Results from a Turkish Nationwide Study.

Rifat Emral, Cem Haymana, Ibrahim Demirci, Ilker Tasci, Mustafa Sahin, Erman Cakal, Naim Ata, Ugur Unluturk, Tevfik Demir, Derun Ertugrul and 9 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Diabetes therapy : research, treatment and education of diabetes and related disorders, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Rifat EmralDepartment of Endocrinology and Metabolism, Faculty of Medicine, Ankara University, Ankara, Turkey. rifatemral@gmail.com.
Cem HaymanaDepartment of Endocrinology and Metabolism, Gulhane Training and Research Hospital, University of Health Sciences, Ankara, Turkey.
Ibrahim DemirciDepartment of Endocrinology and Metabolism, Gulhane Training and Research Hospital, University of Health Sciences, Ankara, Turkey.
Ilker TasciDepartment of Internal Medicine, Gulhane Faculty of Medicine and Gulhane Training and Research Hospital, University of Health Sciences, Ankara, Turkey.
Mustafa SahinDepartment of Endocrinology and Metabolism, Faculty of Medicine, Ankara University, Ankara, Turkey.
Erman CakalDepartment of Endocrinology and Metabolism, Faculty of Medicine, Diskapi Yildirim Beyazit Training and Research Hospital, University of Health Sciences, Ankara, Turkey.
Naim AtaDepartment of Strategy Development, Ministry of Health of the Republic of Turkey, Ankara, Turkey.
Ugur UnluturkDepartment of Endocrinology and Metabolism, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Tevfik DemirDepartment of Endocrinology and Metabolism, Dokuz Eylul University, Faculty of Medicine, Izmir, Turkey.
Derun ErtugrulDepartment of Endocrinology and Metabolism, Faculty of Medicine, Kecioren Training and Research Hospital, University of Health Sciences, Ankara, Turkey.
Ibrahim SahinDepartment of Endocrinology and Metabolism, Faculty of Medicine, Inonu University, Malatya, Turkey.
Aysegül AtmacaDepartment of Endocrinology and Metabolism, Faculty of Medicine, Ondokuz Mayis University, Samsun, Turkey.
Osman CelikPublic Hospitals General Directorate, Ministry of Health of the Republic of Turkey, Ankara, Turkey.
Murat CaglayanAnkara Provincial Health Directorate, Ankara, Turkey.
Kazim Yalcin ArgaDepartment of Bioengineering, Faculty of Engineering, Marmara University, Istanbul, Turkey.
Selcuk DagdelenDepartment of Endocrinology and Metabolism, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Serpil SalmanDepartment of Endocrinology and Metabolism, Medica Clinic, Istanbul, Turkey.
Ilhan SatmanInstitute of Public Health and Chronic Diseases, The Health Institutes of Turkey, Istanbul, Turkey.
Alper SonmezDepartment of Endocrinology and Metabolism, Gulhane Faculty of Medicine and Gulhane Training and Research Hospital, University of Health Sciences, Ankara, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34559403
PMCPMC8461138

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.